— Know what they know.
Not Investment Advice

2196.HK

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
1W: -2.5% 1M: -7.3% 3M: -17.1% YTD: -10.8% 1Y: +37.9% 3Y: -27.0% 5Y: -44.2%
HK$18.79 ($2.40)
-0.15 (-0.79%)
 
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK$65.1B
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market CapHK$65.1B ($8.3B)
52W Range12.78-29
Volume2,392,009
Avg Volume2,870,017
Beta0.69
DividendHK$0.35
Analyst Ratings
No analyst coverage
Company Info
CEOYi Liu
Employees40,557
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2012-10-30
Building A
Shanghai 200233
CN
86 21 3398 7000
About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms